Viewing Study NCT06607302


Ignite Creation Date: 2025-12-25 @ 3:45 AM
Ignite Modification Date: 2026-01-11 @ 1:00 PM
Study NCT ID: NCT06607302
Status: RECRUITING
Last Update Posted: 2025-11-26
First Post: 2024-09-16
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Ivosidenib in Locally Advanced or Metastatic Cholangiocarcinoma With IDH1 R132 Mutation After at Least One Prior Systemic Treatment - an Observational Study
Sponsor: iOMEDICO AG
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Outcomes Module Eligibility Module Contacts Locations Module References Module